Clinical trial
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid…
NCT00235560 · University Hospital, Toulouse, Other · Completed
Key facts
| NCT number | NCT00235560 |
|---|---|
| Title | Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients |
| Official title | Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients. A Study From the Groupe Ouest Est d'étude Des Leucémies Aiguës Myéloïdes (GOELAMS) |
| Acronym | LAM-RAPA |
| Lead sponsor | University Hospital, Toulouse, Other |
| Collaborators | French Innovative Leukemia Organisation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | rapamycin |
| Enrollment | 50 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Oct 10, 2005 |
| Last update posted | Feb 29, 2024 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: